Literature DB >> 19688123

Staphylococcal endocarditis presenting with a renal infarct in a patient with acute lymphoblastic leukemia.

Meong Hi Son1, Eun Sil Park, Ji-Hyun Seo, Jae-Young Lim, Chan-Hoo Park, Hyang-Ok Woo, Hee-Shang Youn.   

Abstract

We present here a patient with acute lymphoblastic leukemia (ALL) and who developed infective endocarditis during induction chemotherapy with prednisolone, L-asparaginase (Leunase), vincristine and adriamycin. The patient did not have a history of a central venous catheter. Sharp flank pain and fever occurred on the 25(th) day of induction chemotherapy. In addition, a renal infarct and movable vegetations on the mitral valve were detected on the abdominal computed tomography (CT) and echocardiography. S. aureus was identified in the cultured blood. While the patient achieved remission, follow-up echocardiography revealed the vegetation had increased in size and an abscess pocket had developed despite the antibiotics and heparin therapy. Consequently, ten days after the diagnosis of infective endocarditis, a successful mitral valvuloplasty was performed without complications. The patient is currently on maintenance chemotherapy while in remission.

Entities:  

Keywords:  Coagulation; Precursor cell lymphoblastic leukemia-lymphoma; Staphylococcus aureus; Vegetation

Year:  2008        PMID: 19688123      PMCID: PMC2697465          DOI: 10.4143/crt.2008.40.3.151

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  13 in total

1.  Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Ann F Bolger; Matthew E Levison; Patricia Ferrieri; Michael A Gerber; Lloyd Y Tani; Michael H Gewitz; David C Tong; James M Steckelberg; Robert S Baltimore; Stanford T Shulman; Jane C Burns; Donald A Falace; Jane W Newburger; Thomas J Pallasch; Masato Takahashi; Kathryn A Taubert
Journal:  Circulation       Date:  2005-06-14       Impact factor: 29.690

2.  Peptidoglycan from Staphylococcus aureus induces tissue factor expression and procoagulant activity in human monocytes.

Authors:  Eva Mattsson; Heiko Herwald; Lars Björck; Arne Egesten
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  Thrombosis related to the use of L-asparaginase in adults with acute lymphoblastic leukemia: a need to consider coagulation monitoring and clotting factor replacement.

Authors:  S R Alberts; M Bretscher; J C Wiltsie; B P O'Neill; B Mokri; T E Witzig
Journal:  Leuk Lymphoma       Date:  1999-02

4.  Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits.

Authors:  T A Drake; G M Rodgers; M A Sande
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

5.  Identification of abscess formation in native-valve infective endocarditis using transesophageal echocardiography: implications for surgical treatment.

Authors:  S Rohmann; T Seifert; R Erbel; H Jakob; S Mohr-Kahaly; T Makowski; G Görge; H Oelert; J Meyer
Journal:  Thorac Cardiovasc Surg       Date:  1991-10       Impact factor: 1.827

6.  Thrombosis in children receiving L-asparaginase. Determining patients at risk.

Authors:  A D Shapiro; S L Clarke; J M Christian; L F Odom; W E Hathaway
Journal:  Am J Pediatr Hematol Oncol       Date:  1993-11

7.  A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.

Authors:  Lesley G Mitchell; Maureen Andrew; Kim Hanna; Thomas Abshire; Jacqueline Halton; Ron Anderson; Irene Cherrick; Sunil Desai; Donald Mahoney; Patricia McCuster; John Wu; Gary Dahl; Peter Chait; Gabrielle de Veber; Kyong-Jin Lee; David Mikulis; Jeffrey Ginsberg; Cliford Way
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

8.  Monocytes maintain tissue factor activity after cytolysis of bacteria-infected endothelial cells in an in vitro model of bacterial endocarditis.

Authors:  Marcel H A M Veltrop; Henry Beekhuizen
Journal:  J Infect Dis       Date:  2002-09-25       Impact factor: 5.226

9.  Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach.

Authors:  A Mügge; W G Daniel; G Frank; P R Lichtlen
Journal:  J Am Coll Cardiol       Date:  1989-09       Impact factor: 24.094

10.  Highly purified lipoteichoic acid from Staphylococcus aureus induces procoagulant activity and tissue factor expression in human monocytes but is a weak inducer in whole blood: comparison with peptidoglycan.

Authors:  Eva Mattsson; Thomas Hartung; Siegfried Morath; Arne Egesten
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more
  2 in total

1.  Infective endocarditis presenting with loin pain.

Authors:  Ali Kohansal; Valerie A Luyckx
Journal:  BMJ Case Rep       Date:  2011-01-11

2.  Acute Lymphoblastic Leukemia with Infective Endocarditis Presented with Unusual Intracardiac Mass.

Authors:  Ali Sadeghpour Tabaei; Leili Koochakzadeh; Mohammadrafie Khorgami; Sepehr Sadeghpour Tabaei
Journal:  Case Rep Cardiol       Date:  2017-05-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.